These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29296749)

  • 61. CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group.
    Lamble AJ; Eidenschink Brodersen L; Alonzo TA; Wang J; Pardo L; Sung L; Cooper TM; Kolb EA; Aplenc R; Tasian SK; Loken MR; Meshinchi S
    J Clin Oncol; 2022 Jan; 40(3):252-261. PubMed ID: 34855461
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunotherapy in Acute Myeloid Leukemia: Where We Stand.
    Isidori A; Cerchione C; Daver N; DiNardo C; Garcia-Manero G; Konopleva M; Jabbour E; Ravandi F; Kadia T; Burguera AF; Romano A; Loscocco F; Visani G; Martinelli G; Kantarjian H; Curti A
    Front Oncol; 2021; 11():656218. PubMed ID: 34041025
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    Wong KK; Hassan R; Yaacob NS
    Front Oncol; 2021; 11():624742. PubMed ID: 33718188
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CD123 Is Consistently Expressed on
    Perriello VM; Gionfriddo I; Rossi R; Milano F; Mezzasoma F; Marra A; Spinelli O; Rambaldi A; Annibali O; Avvisati G; Di Raimondo F; Ascani S; Falini B; Martelli MP; Brunetti L
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33525388
    [No Abstract]   [Full Text] [Related]  

  • 65. CD123 as a Biomarker in Hematolymphoid Malignancies: Principles of Detection and Targeted Therapies.
    El Achi H; Dupont E; Paul S; Khoury JD
    Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33113953
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
    Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
    Front Immunol; 2020; 11():1280. PubMed ID: 32849491
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo.
    Baroni ML; Sanchez Martinez D; Gutierrez Aguera F; Roca Ho H; Castella M; Zanetti SR; Velasco Hernandez T; Diaz de la Guardia R; Castaño J; Anguita E; Vives S; Nomdedeu J; Lapillone H; Bras AE; van der Velden VHJ; Junca J; Marin P; Bataller A; Esteve J; Vick B; Jeremias I; Lopez A; Sorigue M; Bueno C; Menendez P
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32527933
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Class C CpG Oligodeoxynucleotide Immunomodulatory Response in Aged Squirrel Monkey (
    Nehete PN; Williams LE; Chitta S; Nehete BP; Patel AG; Ramani MD; Wisniewski T; Scholtzova H
    Front Aging Neurosci; 2020; 12():36. PubMed ID: 32194391
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies.
    Testa U; Pelosi E; Castelli G
    Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31547472
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Single-Chain Variable Fragment-Based Bispecific Antibodies: Hitting Two Targets with One Sophisticated Arrow.
    Ahamadi-Fesharaki R; Fateh A; Vaziri F; Solgi G; Siadat SD; Mahboudi F; Rahimi-Jamnani F
    Mol Ther Oncolytics; 2019 Sep; 14():38-56. PubMed ID: 31011631
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A dual role for the N-terminal domain of the IL-3 receptor in cell signalling.
    Broughton SE; Hercus TR; Nero TL; Kan WL; Barry EF; Dottore M; Cheung Tung Shing KS; Morton CJ; Dhagat U; Hardy MP; Wilson NJ; Downton MT; Schieber C; Hughes TP; Lopez AF; Parker MW
    Nat Commun; 2018 Jan; 9(1):386. PubMed ID: 29374162
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A; Gillis D; Lewis I
    J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells.
    Jordan CT; Upchurch D; Szilvassy SJ; Guzman ML; Howard DS; Pettigrew AL; Meyerrose T; Rossi R; Grimes B; Rizzieri DA; Luger SM; Phillips GL
    Leukemia; 2000 Oct; 14(10):1777-84. PubMed ID: 11021753
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells.
    Jin L; Lee EM; Ramshaw HS; Busfield SJ; Peoppl AG; Wilkinson L; Guthridge MA; Thomas D; Barry EF; Boyd A; Gearing DP; Vairo G; Lopez AF; Dick JE; Lock RB
    Cell Stem Cell; 2009 Jul; 5(1):31-42. PubMed ID: 19570512
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CD123 and its potential clinical application in leukemias.
    Liu K; Zhu M; Huang Y; Wei S; Xie J; Xiao Y
    Life Sci; 2015 Feb; 122():59-64. PubMed ID: 25445480
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High CD123 levels enhance proliferation in response to IL-3, but reduce chemotaxis by downregulating CXCR4 expression.
    Wittwer NL; Brumatti G; Marchant C; Sandow JJ; Pudney MK; Dottore M; D'Andrea RJ; Lopez AF; Ekert PG; Ramshaw HS
    Blood Adv; 2017 Jun; 1(15):1067-1079. PubMed ID: 29296749
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03).
    Cooper TM; Sison EAR; Baker SD; Li L; Ahmed A; Trippett T; Gore L; Macy ME; Narendran A; August K; Absalon MJ; Boklan J; Pollard J; Magoon D; Brown PA
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28409853
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hematopoietic Stem Cell Niches Produce Lineage-Instructive Signals to Control Multipotent Progenitor Differentiation.
    Cordeiro Gomes A; Hara T; Lim VY; Herndler-Brandstetter D; Nevius E; Sugiyama T; Tani-Ichi S; Schlenner S; Richie E; Rodewald HR; Flavell RA; Nagasawa T; Ikuta K; Pereira JP
    Immunity; 2016 Dec; 45(6):1219-1231. PubMed ID: 27913094
    [TBL] [Abstract][Full Text] [Related]  

  • 79. T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments.
    Hawkins ED; Duarte D; Akinduro O; Khorshed RA; Passaro D; Nowicka M; Straszkowski L; Scott MK; Rothery S; Ruivo N; Foster K; Waibel M; Johnstone RW; Harrison SJ; Westerman DA; Quach H; Gribben J; Robinson MD; Purton LE; Bonnet D; Lo Celso C
    Nature; 2016 Oct; 538(7626):518-522. PubMed ID: 27750279
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.